
Adicet Bio, Inc. Share Price
ACET$0.77
+$0.05 (6.32%) Last updated on 09 Sep, 2025 | 01:28 ISTAdicet Bio, Inc. Stock Performance
Open $0.71 | Prev. Close $0.72 | Circuit Range N/A |
Day Range $0.70 - $0.77 | Year Range $0.45 - $1.63 | Volume 8,937 |
Average Traded $0.74 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
Day | Open | Close | Change % |
---|---|---|---|
08-Sep-25 | $0.71 | $0.77 | +0.00% |
08-Sep-25 | $0.71 | $0.77 | +6.25% |
05-Sep-25 | $0.72 | $0.72 | +0.28% |
04-Sep-25 | $0.72 | $0.72 | -1.64% |
03-Sep-25 | $0.73 | $0.73 | -0.14% |
02-Sep-25 | $0.74 | $0.73 | +1.25% |
29-Aug-25 | $0.72 | $0.72 | -5.00% |